Emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

HIV infection

Manufacturer:

Gilead Science Canada Ltd.

Call for patient/clinician input open:

October 11, 2011

Brand Name:

COMPLERA

Project Line:

Reimbursement Review

Project Number:

SR0256-000

Call for patient/clinician input closed:

November 9, 2011

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

HIV-1 infection in antiretroviral treatment- naïve adults

Recommendation Type:

List

Final Recommendation:

April 19, 2012

Last Updated : October 19, 2011